OLD: Cafepharma Detail Piece Daily Pharma Headlines Archive for February, 2013

IMPORTANT: On Sunday, April 22, we send out an email with some important changes to our newsletter service. Please make sure you read this email, or the details on our our newsletter page, as our newsletter service changes will be taking effect on Monday, May 7, 2018.  On that date, your current newsletter subscription will end if you have not subscribed under our new plan. 

Click a link below to view the mailing archive as if it had been sent to you. 2013-02-28 12:00 Valeant Earnings Seen Rising As Firm Digests Medicis and more... 2013-02-28 00:00 Why Sarepta Therapeutics Shares Shot Higher and more... 2013-02-26 12:00 Reimbursement battle for Qsymia hits Vivus figures and more... 2013-02-25 12:00 Obama And Access To Federally Funded Research and more... 2013-02-25 00:00 Strides Arcolab looks to sell stake worth Rs 4,885 cr and more... 2013-02-22 12:00 Vivus, Inc.: Second Rejection And Upcoming Earnings, Patience Required For Investors and more... 2013-02-22 00:00 Regulators Await Gilead's Hep C Candidate and more... 2013-02-21 12:00 Studies Examine Novel Use For New Oral Anticoagulant Drugs Comment Now Follow Comments and more... 2013-02-21 00:00 Can JAK Inhibitors Challenge Biologics? and more... 2013-02-20 00:00 Ziopharm: What Happens Next? and more... 2013-02-19 12:00 Osiris Therapeutics Successfully Defends Key Stem Cell Patent Challenge and more... 2013-02-19 00:00 Actelion Looks Within as Competition Lifts Drug Prices and more... 2013-02-18 00:00 Better Buy: Pfizer or Zoetis? and more... 2013-02-17 00:00 The Next Stock You Should Consider and more... 2013-02-16 00:00 Incyte Earnings: HereâÔö£é?öé??Ôö£é?ö?ñós Why Investors are Happy Now and more... 2013-02-15 12:00 Eisai gets orphan drug status for Lenvatinib and more... 2013-02-14 12:00 AVEO: Final Overall Survival Results From The TIVO?ë?£Ôö£éÔö¼?í1 Study and more... 2013-02-13 12:00 Cumberland Pharmaceuticals: A Rare Value Stock In The Drug Industry and more... 2013-02-13 00:00 Promising Italian Biotech With An Upcoming CHMP Meeting and more... 2013-02-12 12:00 Will Johnson & Johnson Win Approval for Its Diabetes Drug? and more... 2013-02-12 00:00 Backed By Large Pharma And Key Investors, Pharmacyclics Is Set To Climb Higher and more... 2013-02-11 12:00 2 Stem Cell Research Pioneers And Where They Are Today and more... 2013-02-11 00:00 Allergan wants to trim obesity treatment unit and more... 2013-02-10 00:00 J&J President Visited Hip Surgeon Pre-Recall, Jury Told and more... 2013-02-09 12:00 Has Gilead Sciences Become the Perfect Stock? and more... 2013-02-09 00:00 Analysis: Amgen fighting on both sides of the biosimilars battle and more... 2013-02-08 12:00 One Down, 13 To Go: A Biosimilar Bill Falls Flat and more... 2013-02-08 00:00 Knee replacement: Stanmore nabs FDA clearance for robotic guidance system and more... 2013-02-07 12:00 Elan seeks acquisitions after $3.25 bn Biogen Idec deal, rival Bayer eyed on MS treatments and more... 2013-02-06 12:00 Merck loses 'bellwether' Fosamax case and more... 2013-02-06 00:00 Med-tech trends: The most talked about device makers in January 2013 and more... 2013-02-05 12:00 Glaxo Clashes With PhRMA Over Data Disclosure and more... 2013-02-05 00:00 Feds grab Shire's attention on Adderall marketing and more... 2013-02-04 00:00 3 Ways to Make Money With Zoetis (Even If You Missed the IPO) and more... 2013-02-03 00:00 Aegerion Pharmaceuticals Expected To Take A Hit and more... 2013-02-02 00:00 Gilead Seeks Blood Cancer Drugs to Bolster HIV Business 2013-02-01 12:00 Sales growth lifts CR Bard's 4Q profit and more...   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz

Contact Us Past Issues Unsubscribe